Litigation Details for PAR PHARMACEUTICAL, INC. v. CIPLA LIMITED (D.N.J. 2022)
✉ Email this page to a colleague
PAR PHARMACEUTICAL, INC. v. CIPLA LIMITED (D.N.J. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-05-13 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 9,981,006 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in PAR PHARMACEUTICAL, INC. v. CIPLA LIMITED
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for PAR PHARMACEUTICAL, INC. v. CIPLA LIMITED (D.N.J. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-07-13 | 9 | Amended Complaint | 2268 “’649 Patent”), 9,974,827 (the “’827 Patent”), 9,981,006 (the “’006 Patent”), 10,010,575 (the… United States Patent Nos. 9,919,026 (the “’026 Patent”), 9,925,233 (the “’233 Patent”), 9,962,422 (…(the “’575 Patent”), and 9,925,234 (the “’234 Patent”) (collectively the “Patents-in-Suit”). This …copy of the ’026 Patent is attached as Exhibit A. Par Pharmaceutical owns the ’026 Patent. …copy of the ’233 Patent is attached as Exhibit B. Par Pharmaceutical owns the ’233 Patent. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
